Journal article
A multi-center, adaptive, randomized, platform trial to evaluate the effect of repurposed medicines in outpatients with early coronavirus disease 2019 (COVID-19) and high-risk for complications: the TOGETHER master trial protocol
Abstract
Background:
Although vaccines are currently available for coronavirus disease 2019 (COVID-19), there remains a need for an effective and affordable outpatient treatment for early COVID-19. Multiple repurposed drugs have shown promise in treating COVID-19. We describe a master protocol that will assess the efficacy of different repurposed drugs as treatments for early COVID-19 among outpatients at a high risk for severe …
Authors
Reis G; dos Santos Moreira Silva EA; Silva DCM; Thorlund K; Thabane L; Guyatt GH; Forrest JI; Glushchenko AV; Chernecki C; McKay P
Journal
Gates Open Research, Vol. 5, ,
Publisher
F1000Research
DOI
10.12688/gatesopenres.13304.1
ISSN
2572-4754